BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
147 hedge funds and large institutions have $1.69B invested in Audentes Therapeutics, Inc in 2019 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
+8
Holders Change %
+5.76%
% of All Funds
3.2%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
32
Increased
62
Reduced
34
Closed
21
Calls
$10.3M
Puts
$2.7M
Net Calls
+$7.56M
Net Calls Change
+$4.87M
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$51.9M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
$122M |
| 3 |
State Street
Boston,
Massachusetts
|
$70.3M |
| 4 |
BlackRock
New York
|
$126M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$72.8M |
